Andrew Cittadine

Company: Monopar Therapeutics

Job title: Chief Operating Officer

Seminars:

Advancing Chelator Technologies for Enhanced Radiopharmaceutical Development 2:00 pm

Promoting altered drug properties Outlining chelators of choice Improving the pharmacokinetics and biodistribution of radiopharmaceuticalsRead more

day: Conference Day Two

Assessing Radiopharmaceutical Pharmacokinetics: Tools & Technologies 1:33 pm

Traditional small molecule drug development has well established assays, tools and technologies for preclinical research, but in the evolving world of radiopharmaceuticals specialised tools are required. Delve into this workshop to explore: Preclinical Imaging for PK Evaluation: Discover how small-animal PET, SPECT, and MRI are utilized in preclinical models to visualize and quantify radiopharmaceutical biodistribution,…Read more

day: Pre-Conference Workshop Day